ESC 2024: INFINITY-SWEDEHEART Trial Confirms DynamX Bioadaptor Success
Elixir Medical, a developer of innovative cardiovascular technologies, announced that the INFINITY-SWEDEHEART Randomized Controlled Trial (RCT) has met its primary endpoint. The trial compared the novel DynamX® Coronary Bioadaptor System…
Daiichi Sankyo Highlights Gaps in Cardiovascular Care
Daiichi Sankyo Europe today reaffirmed its dedication to tackling unmet needs and barriers in cardiovascular care by highlighting treatment disparities and outcomes among different patient groups. This announcement coincides with…
Updated Flu and COVID-19 Shots Now at CVS Pharmacy® and MinuteClinic®
CVS Pharmacy® (NYSE: CVS) has announced that the updated 2024-2025 flu and COVID-19 vaccines are now available at CVS Pharmacy and MinuteClinic® locations nationwide. Patients can walk in for a…
UnitedHealthcare Grants $114,500 to Seven Iowa Organizations for Social Drivers of Health
UnitedHealthcare has awarded $114,500 to seven Iowa organizations to enhance health outcomes by addressing social determinants of health. This funding aligns with UnitedHealthcare’s goal to positively impact underserved communities and…
Collaborative Bridges Selects HealthEC for Behavioral Health Care Coordination
Collaborative Bridges, a network of West Side Chicago safety net hospitals and mental health agencies, has selected HealthEC’s data and analytics solution to enhance care coordination for behavioral health patients.…
OS Therapies Completes OST-HER2 Phase 2b Trial Enrollment and Final Treatment Dose
OS Therapies Incorporated (NYSE American: OSTX) announced today that the last patient (Patient #41) in the AOST-2121 clinical trial of OST-HER2 for recurrent, resected Osteosarcoma has received their final treatment…
Noetik Secures $40M Series A to Advance Precision Cancer Therapies
Noetik, an AI-driven biotech firm using self-supervised machine learning and high-throughput spatial data to create cutting-edge cancer therapies, has announced the successful closure of an oversubscribed $40 million Series A…
Kiyatec Publishes Study on 3D Predict™ for High-Grade Glioma
Kiyatec, a leader in functional precision oncology, has announced the publication of a key study in Scientific Reports showcasing the benefits of the 3D Predict Glioma test for high-grade glioma…
Jupiter Endovascular Gets FDA Nod for Vertex Pulmonary Embolectomy System Pivotal Study
Jupiter Endovascular, Inc., a medical tech innovator specializing in advanced endovascular procedures through Endoportal Control™, has received FDA approval for its Investigational Device Exemption application. This approval clears the way…
CharmHealth Announces 2024 Innovation Challenge Winners
CharmHealth, a leader in healthcare technology solutions, has unveiled the winners of its 2024 Innovation Challenge. Entering its fourth year, the challenge aims to discover groundbreaking ideas poised to transform…
Renata Medical’s Minima Growth Stent Gains FDA Approval for Aortic Coarctation and Pulmonary Artery Stenosis
Renata Medical has announced that the U.S. Food and Drug Administration (FDA) has approved its innovative Minima Growth Stent, designed specifically for neonates, infants, and young children. This unique stent…
ASM Announces Retirement of Founder and CEO Trung Phan
Applied Statistics & Management Inc. (ASM), a top provider of medical staff credentialing and privileging solutions, has announced the retirement of its founder, President, and CEO, Trung Phan. Trung Phan…